Assessment of Prognostic and Therapeutic Factors in Male Breast Cancer: An Observational Study of a Southwest Spanish Single Center
Herrero, Daniel, Morales Herrero, María Rocío, López Guerra, José Luis, Camacho-Mejías, Alberto Sánchez, García, Irene Carrasco, Fernández, Paloma Santos, Almeida González, Carmen Victoria, Viñuales, Marta Benavent, González, Alejandro Falcón, Periáñez, Álvaro Montaño, Mancha, Rosario González, Salvador Bofill, Francisco Javier, Borrego, Manuel Ruiz
Published in Archives of breast cancer (01.11.2020)
Published in Archives of breast cancer (01.11.2020)
Get full text
Journal Article
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
Brasó-Maristany, Fara, Ferrero-Cafiero, Juan Manuel, Falato, Claudette, Martínez-Sáez, Olga, Cejalvo, Juan Miguel, Margelí, Mireia, Tolosa, Pablo, Salvador-Bofill, Francisco Javier, Cruz, Josefina, González-Farré, Blanca, Sanfeliu, Esther, Òdena, Andreu, Serra, Violeta, Pardo, Francisco, Luna Barrera, Ana María, Arumi, Miriam, Guerra, Juan Antonio, Villacampa, Guillermo, Sánchez-Bayona, Rodrigo, Ciruelos, Eva, Espinosa-Bravo, Martín, Izarzugaza, Yann, Galván, Patricia, Matito, Judith, Pernas, Sonia, Vidal, Maria, Santhanagopal, Anu, Sellami, Dalila, Esker, Stephen, Fan, Pang-Dian, Suto, Fumitaka, Vivancos, Ana, Pascual, Tomás, Prat, Aleix, Oliveira, Mafalda
Published in Nature communications (11.07.2024)
Published in Nature communications (11.07.2024)
Get full text
Journal Article
A Cross-Sectional Validation Study of Camry EH101 versus JAMAR Plus Handheld Dynamometers in Colorectal Cancer Patients and Their Correlations with Bioelectrical Impedance and Nutritional Status
Jiménez-Sánchez, Andrés, Pereira-Cunill, José Luis, Limón-Mirón, María Luisa, López-Ladrón, Amelia, Salvador-Bofill, Francisco Javier, García-Luna, Pedro Pablo
Published in Nutrients (01.06.2024)
Published in Nutrients (01.06.2024)
Get full text
Journal Article
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study
Alés-Martínez, José Enrique, Balmaña, Judith, Sánchez-Rovira, Pedro, Salvador Bofill, Francisco Javier, García Sáenz, Jose Ángel, Pimentel, Isabel, Morales, Serafín, Fernández-Abad, María, Lahuerta Martínez, Ainhara, Ferrer, Neus, Zamora, Pilar, Bermejo, Begoña, Díaz-Redondo, Tamara, López-Ceballos, María Helena, Galán, María, Pérez-Escuredo, Jhudit, Calabuig, Laura, Sampayo, Miguel, Pérez-Garcia, José Manuel, Cortés, Javier, Llombart-Cussac, Antonio
Published in Breast (Edinburgh) (01.10.2024)
Published in Breast (Edinburgh) (01.10.2024)
Get full text
Journal Article
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer
Pascual, Tomás, Oliveira, Mafalda, Ciruelos, Eva, Bellet Ezquerra, Meritxell, Saura, Cristina, Gavilá, Joaquin, Pernas, Sonia, Muñoz, Montserrat, Vidal, Maria J, Margelí Vila, Mireia, Cejalvo, Juan M, González-Farré, Blanca, Espinosa-Bravo, Martin, Cruz, Josefina, Salvador-Bofill, Francisco Javier, Guerra, Juan Antonio, Luna Barrera, Ana María, Arumi de Dios, Miriam, Esker, Stephen, Fan, Pang-Dian, Martínez-Sáez, Olga, Villacampa, Guillermo, Paré, Laia, Ferrero-Cafiero, Juan M, Villagrasa, Patricia, Prat, Aleix
Published in Frontiers in oncology (23.04.2021)
Published in Frontiers in oncology (23.04.2021)
Get full text
Journal Article
Abstract P2-26-17: Establishment of an in vitro preclinical platform: A living biobank of patient-derived organoids with ER+ breast cancer
Dominguez-Cejudo, Maria A, Chapresto, Raquel, Gil-Torralvo, Ana, Bofill, Francisco Javier Salvador, Molina-Pinelo, Sonia
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PD13-04: Activity of patritumab deruxtecan, a HER3-directed antibody drug conjugate, in early breast cancer according to ERBB3 expression: Interim analysis results of a window-of-opportunity study (SOLTI-1805 TOT-HER3)
Prat, Aleix, Cejalvo, Juan M., Pare, Laia, Martínez-Sáez, Olga, Vila, Mireia Margelí, Falato, Claudette, Cruz, Josefina, de Dios, Miriam Arumí, Vidal, Maria J, Guerra, Juan Antonio, Barrera, Ana Maria Luna, Tolosa, Pablo, Salvador-Bofill, Francisco Javier, Pernas, Sonia, Gonzáles-Farré, Blanca, Sanfeliu, Esther, Ciruelos, Eva, Serra, Violeta, Espinosa-Bravo, Martin, Izarzugaza, Yann, Esker, Stephen, Fan, Pang-Dian, Villacampa, Guillermo, Ferrero-Cafiero, Juan M, Pascual, Tomás, Oliveira, Mafalda
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract PO1-27-07: Is HER2-low a biologically distinct breast cancer (BC) subtype? Prognosis and pathological complete response rate after neoadjuvant treatment (NAT) in early breast cancer (BC) HER2 negative
Gil-Torralvo, Ana, Rodriguez, Yeray, Falcon, Alejandro, Morales, David, Cejuela, Mónica, Miras, Isabel, Amérigo, Marta, Ruíz - Borrego, Manuel, Bayo, Juan, Bofill, Francisco Javier Salvador
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract P3-01-13: Palbociclib, ribociclib and abemaciclib in real-world data: risk of disease progression on first-line treatment of metastatic breast cancer
Cejuela, Mónica, Castilla, M. ángeles, Benavent, Marta, Molina-Pinelo, Sonia, Dominguez-Cejudo, Maria A, Gil, Ana, Falcon, Alejandro, Bofill, Francisco Javier Salvador
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PO3-05-06: Targeting PAM50 HER2-Enriched intrinsic subtype with enzalutamide in hormone receptor-positive/HER2-negative (HR+/HER2-) advanced breast cancer: results of the SOLTI-1502 ARIANNA trial
Oliveira, Mafalda, Pascual, Tomás, Pernas, Sonia, Margelí, Mireia, Blanch, Salvador, Adamo, Barbara, Bofill, Francisco Javier Salvador, Gonzalez-Farré, Xavier, Chillara, Samyukta, Galván, Patricia, Sanfeliu, Esther, Blasco, Paula, Sirenko, Valeria, Espinosa, Alejandra, Perou, Charles M, Prat, Aleix, Manso, Luis
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Abstract P1-04-18: Identification of UGT2B family genes as potential biomarkers of response to neoadjuvant therapy in HER2+ breast cancer
Gil-Torralvo, Ana, Benavent, Marta, Dominguez-Cejudo, Maria A, Falcon, Alejandro, Cejuela, Mónica, Vieites, Begoña, Molina-Pinelo, Sonia, Borrego, Manuel Ruiz, de la Haba-Rodríguez, Juan, Queipo, Maria I, Bofill, Francisco Javier Salvador
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract PO3-05-07: SOLTI-1718 NEREA Trial: Neratinib in hormone receptor (HR)-positive/HER2-negative HER2-enriched (HER2-E) advanced breast cancer (BC)
Ciruelos, Eva, Saura, Cristina, Gonzalez-Farré, Xavier, Bofill, Francisco Javier Salvador, Vidal, Maria, Blancas, Isabel, López-Miranda, Elena, Iglesias, Maria, Arumí, Míriam, Margelí, Mireia, Pulido, Catarina, Murillo, Serafin Morales, Henao, Fernando, Sanchez, Pilar, Alves, Sara, Ortiz, Ana Godoy, Coelho, José Passos, Escrivá-de-Romaní, Santiago, Espinosa, Alejandra, Pascual, Tomás, Prat, Aleix
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Published in Cancer research (Chicago, Ill.) (02.05.2024)
Get full text
Journal Article
Magnetic Resonance Diffusion as Predictive Value of Response to Treatment with Chemo-Radiotherapy in Patients with Locally Advanced Rectal Cancer
Inmaculada, Gallego Jimenez, Susana, Rico Gala, Amelia, López-Ladrón, Fernández-Parra Eva, M., David, Morales Pancorbo, Javier, Salvador Bofill Francisco
Published in Annals of oncology (01.06.2014)
Published in Annals of oncology (01.06.2014)
Get full text
Journal Article
Abstract P5-02-31: Genetic determinants of response to patritumab deruxtecan (HER3-DXd) in hormone receptor-positive/HER2-negative (HR+/HER2-) breast cancer: a correlative analysis from SOLTI TOT-HER3 trial
Brasó-Maristany, Fara, Falato, Claudette, Martínez-Sáez, Olga, Cejalvo, Juan Miguel, Margelí, Mireia, Tolosa, Pablo, Bofill, Francisco Javier Salvador, Cruz, Josefina, González-Farré, Blanca, Sanfeliu, Esther, Arumí, Míriam, Villacampa, Guillermo, Ciruelos, Eva, Espinosa-Bravo, Martín, Izarzuzaga, Yann, Galván, Patricia, Matito, Judit, Pernas, Sonia, Santhanagopal, Anu, Esker, Stephen, Patel, Parul, Fan, Pang-Dian, Ferrero-Cafiero, Juan Manuel, Vivancos, Ana, Pascual, Tomás, Prat, Aleix, Oliveira, Mafalda
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract OT2-08-02: SOLTI-1907 ATREZZO: Targeting hormonal receptor negative (HR-) or PAM50 non-luminal disease with atezolizumab in combination with trastuzumab and vinorelbine in HER2-positive metastatic breast cancer (MBC)
Ciruelos, Eva, Perelló, Antonia, González-Santiago, Santiago, López, Ana, Bofill, Francisco Javier Salvador, Albacar, Cinta, Cejalvo, Juan Miguel, Escrivá-de-Romani, Santiago, Blancas, Isabel, Pernas, Sonia, Martínez-Sáez, Olga, Cruz, Josefina, Ponce, Jose, Servitja, Sonia, Perez-Lopez, Maria-Eva, Guerra, Juan A, Sanfeliu, Esther, Rodríguez, Cesar A, Villacampa, Guillermo, Villanueva, Lorea, Tolosa, Pablo, Pascual, Tomás, Prat, Aleix
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Abstract P4-07-29: Olaparib plus Trastuzumab in HER2[+] BRCA-Mutated Advanced Breast Cancer Patients: The OPHELIA Study
Alés-Martínez, José E., Balmaña, Judith, Sánchez-Rovira, Pedro, Bofill, Francisco Javier Salvador, García-Sáenz, José Ángel, Pimentel, Isabel, Murillo, Serafin Morales, Fernández, Adela, Martínez, Ainhara Lahuerta, Ferrer, Neus, Zamora, Pilar, Bermejo, Begoña, Díaz-Redondo, Tamara, Lopez-Ceballos, María Helena, Galán, María, Malfettone, Andrea, Calabuig, Laura, Sampayo-Cordero, Miguel, Pérez-García, José Manuel, Cortés, Javier, Llombart-Cussac, Antonio
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Published in Cancer research (Chicago, Ill.) (01.03.2023)
Get full text
Journal Article
Cross-sectional observational study to describe the clinicopathological and biological characteristics and the management of patients with HER2+ metastatic breast cancer who experienced complete or partial remission or disease stabilization during at least 3 years: LongHer study
Zamora, Pilar, Fresno-Vara, Juan Angel, Gámez-Pozo, Angelo, Perez-Carrion, Ramon, Manso, Luis, Crespo Massieu, Carmen, Mendiola, Cesar, Alvarez, Isabel, Margeli Vila, Mireia, Bayo Calero, Juan Lucas, Gonzalez, Xavier, Santaballa, Ana, Ciruelos Gil, Eva Maria, Afonso Gomez, Ruth, Lao Romera, Juan, Catalan, Gustavo, Alvarez Gallego, Jose Valero, Miramon Lopez, Jose, Salvador Bofill, Francisco Javier, Ruiz Borrego, Manuel
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
IN VITRO METHOD FOR PREDICTING THE RESPONSE OF PATIENTS SUFFERING FROM HER2+ BREAST CANCER TO A TREATMENT WITH ANTI-HER2 NEOADJUVANT THERAPY
MOLINA PINELO, Sonia, GIL TORRALVO, Ana, SALVADOR BOFILL, Francisco Javier, DOMINGUEZ CEJUDO, María Ángeles, GARRIGÓS VACAS, Carmen
Year of Publication 08.06.2023
Get full text
Year of Publication 08.06.2023
Patent
UGT2B17 as a predictor of response to neoadjuvant therapy in patients with HER2-positive and hormone receptor-negative breast cancer (Machine-translation by Google Translate, not legally binding)
MOLINA PINELO, Sonia, DOMINGUEZ CEJUDO, María Angeles, GIL TORRALVO, Ana, SALVADOR BOFILL, Francisco Javier, GARRIGOS VACAS, Carmen
Year of Publication 23.07.2024
Get full text
Year of Publication 23.07.2024
Patent
UGT2B10 as a predictor of response to neoadjuvant therapy in patients with HER2-positive and hormone receptor-negative breast cancer (Machine-translation by Google Translate, not legally binding)
MOLINA PINELO, Sonia, DOMINGUEZ CEJUDO, María Angeles, GIL TORRALVO, Ana, SALVADOR BOFILL, Francisco Javier, GARRIGOS VACAS, Carmen
Year of Publication 22.07.2024
Get full text
Year of Publication 22.07.2024
Patent